A new app combines basic data with information about specific biomarkers found in an individual's blood to assess the risk of developing Alzheimer's disease within two to four years.
Tau spreads through the human brain via neural communication pathways. The spread is accelerated by the presence of amyloid-beta.
Researchers have developed a new model of early embryonic brain development. The model, called MiSTR, allows researchers to create tissue that contains different brain regions and place them next to each other. The model produces results similar to embryonic brain development at five weeks post-fertilization.
By the age of six months, infants can recognize when an adult imitates them and perceive the imitator as more friendly.
The neuropeptide NPY reduces seizures in human brain tissue.
A new blood test to detect biomarkers for Alzheimer's disease is set to undergo trials in the Fall. The test will be able to identify traces of amyloid beta in blood samples with a high degree of accuracy.
Neurofilament light protein in plasma may be a noninvasive biomarker for neurodegeneration associated with Alzheimer's disease.
Researchers report the great tit, a common European songbird, has similar impulse control to that of larger, more cognitively advanced animals.
Researchers report they have discovered where the earliest signs of Alzheimer's may occur in the brain. Initial accumulation of Alzheimer's associated amyloid beta was discovered in an important functional network, the default mode network.
Researchers at Lund University have developed a new imaging method that can help doctors detect and track Alzheimer's disease in people of different ages more effectively.
Researchers reveal the social divide between chimps and humans isn't as clear cut as once thought. Observing both animals and visitors at a zoo, researchers discovered about 10% of the actions produced by one species was an imitation of the other species.
Researchers find the brain's capacity to learn is created than previously thought.
